- Home
- VCEL vs ACLS Comparison
VCEL vs ACLS Comparison
Compare VCEL & ACLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- ACLS
- Stock Information
- Founded
- VCEL 1989
- ACLS 1995
- Country
- VCEL United States
- ACLS United States
- Employees
- VCEL N/A
- ACLS N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- ACLS Industrial Machinery/Components
- Sector
- VCEL Health Care
- ACLS Technology
- Exchange
- VCEL Nasdaq
- ACLS Nasdaq
- Market Cap
- VCEL 2.1B
- ACLS 2.1B
- IPO Year
- VCEL 1997
- ACLS 2000
- Fundamental
- Price
- VCEL $41.83
- ACLS $71.99
- Analyst Decision
- VCEL Strong Buy
- ACLS Buy
- Analyst Count
- VCEL 8
- ACLS 7
- Target Price
- VCEL $62.00
- ACLS $138.00
- AVG Volume (30 Days)
- VCEL 430.3K
- ACLS 665.6K
- Earning Date
- VCEL 07-31-2025
- ACLS 07-30-2025
- Dividend Yield
- VCEL N/A
- ACLS N/A
- EPS Growth
- VCEL 521.85
- ACLS N/A
- EPS
- VCEL 0.05
- ACLS 5.46
- Revenue
- VCEL $238,541,000.00
- ACLS $958,056,000.00
- Revenue This Year
- VCEL $23.03
- ACLS N/A
- Revenue Next Year
- VCEL $24.52
- ACLS $7.62
- P/E Ratio
- VCEL $805.02
- ACLS $13.16
- Revenue Growth
- VCEL 14.80
- ACLS N/A
- 52 Week Low
- VCEL $37.39
- ACLS $40.40
- 52 Week High
- VCEL $63.00
- ACLS $158.61
- Technical
- Relative Strength Index (RSI)
- VCEL 47.28
- ACLS 65.20
- Support Level
- VCEL $40.53
- ACLS $68.33
- Resistance Level
- VCEL $43.57
- ACLS $72.40
- Average True Range (ATR)
- VCEL 1.67
- ACLS 2.67
- MACD
- VCEL -0.10
- ACLS 0.05
- Stochastic Oscillator
- VCEL 27.68
- ACLS 93.81
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.